Online inquiry

IVTScrip™ mRNA-Human ARHGEF39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25019MR)

This product GTTS-WK25019MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGEF39 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_032818.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84904
UniProt ID Q8N4T4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25019MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK28626MR IVTScrip™ mRNA-Human ARID4B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARID4B
GTTS-WK26813MR IVTScrip™ mRNA-Human ARHGEF2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF2
GTTS-WK19054MR IVTScrip™ mRNA-Human AMN1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AMN1
GTTS-WK8645MR IVTScrip™ mRNA-Human ADGRL1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADGRL1
GTTS-WK22969MR IVTScrip™ mRNA-Human ARPC4, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARPC4
GTTS-WK3534MR IVTScrip™ mRNA-Human HGAL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA HGAL
GTTS-WK17854MR IVTScrip™ mRNA-Human AMN1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AMN1
GTTS-WK28047MR IVTScrip™ mRNA-Human ARL6IP1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARL6IP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW